TrialJournal of the American Geriatrics Society2016

Efficacy and Safety of Canagliflozin in Individuals Aged 75 and Older with Type 2 Diabetes Mellitus: A Pooled Analysis.

Alan J Sinclair et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.